PATENT CLAIM ANALYSIS

Application Number: 16370677
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "456000"]

Abstract:
The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.

Claim (Index 25):
The method according to  claim 24 , wherein the pharmaceutical composition does not comprise a sugar alcohol.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.35294
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16370681', '16277689', '15887830', '16280837', '15750811']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.810531662563528
- 35 USC 102 Novelty (BERT): 0.5869330363339688
- Combined Prediction Score: 0.7881717999405721
- Mean Citation Score: 446.273204
- Max Citation Score: 606.9341400000002
- Similarity Product: 372.8766941624595

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test